| abstract |
This disclosure relates to benzamide derivatives of formula (I), or pharmaceutically-acceptable salts thereof which are useful as inhibitors of cytokine mediated disease. The disclosure also relates to processes for the manufacture of said amide derivatives, to pharmaceutical compositions containing said amide derivatives and to their use in therapeutic methods, for example by virtue of inhibition of cytokine mediated disease. |